IP Library Granted Patent US 11,879,007
Granted Patent B2
US 11,879,007 · App. 17/528,025 · Granted Jan 23, 2024

Nucleic acids encoding anti-gliadin antibodies

Inventors: Jingqing Zhang (Hayward, CA); Shireen Taleghani Yates (San Francisco, CA); Scott Erik Sundvor (San Francisco, CA); Alim Seit-Nebi (San Diego, CA)
Assignee: Nima Acquisition, LLC
C07K16/16G01N33/577C07K2317/622C07K2317/92G01N2333/415
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,879,007
App. No.
17/528,025
Granted
Jan 23, 2024
Kind
B2
Abstract

The present invention provides anti-gliadin antibodies and antibody fragments, and polypeptides encoding the antibodies or fragment. Also disclosed are methods and Kits for the use of such antibodies, fragments, or polypeptides in detection of gliadin. Further provided are heavy chain and light chain variable sequences and associated sequences of complementarity-determining regions (CDRs).

Claims (11)

1. An isolated nucleic acid comprising a vector, the vector comprising a polynucleotide sequence encoding a protein, the protein comprising an antibody heavy chain variable region comprising a CDR1 of SEQ ID NO:3, a CDR2 of SEQ ID NO:4, and a CDR3 of SEQ ID NO: 5; an antibody light chain variable region comprising a CDR1 of SEQ ID NO:8, a CDR2 of SEQ ID NO:9, and a CDR3 of SEQ ID NO:10; an antibody a heavy chain variable region comprising a CDR1 of SEQ ID NO: 13, a CDR2 of SEQ ID NO: 14, and a CDR3 of SEQ ID NO: 15; or an antibody light chain variable region comprising a CDR1 of SEQ NO:18, a CDR2 of SEQ ID NO:19, and a CDR3 of SEQ ID NO:20.

2. The nucleic acid of claim 1 , wherein the polynucleotide sequence encodes a protein comprising (1) an antibody heavy chain variable region having the amino acid sequence of SEQ ID NO:2 or 12; or (2) an antibody light chain variable region having the amino acid sequence of SEQ ID NO:7 or 17.

3. The nucleic acid of claim 1 , wherein the polynucleotide sequence is SEQ ID NO:1, 6, 11, or 16.

4. The nucleic acid of claim 1 , further comprising a promoter operably linked to the polynucleotide sequence.

5. A cell comprising the nucleic acid of claim 1 .

6. The cell of claim 5 , wherein the cell is a bacterial cell.

7. The cell of claim 6 , wherein the cell is an Escherichia coli cell.

8. The cell of claim 5 , wherein the cell is a eukaryotic cell.

9. The cell of claim 8 , wherein the cell is selected from a yeast cell, a COS cell, a CHO cell, a HeLa cell, and a myeloma cell.

10. A cell comprising the nucleic acid of claim 4 .

11. The cell of claim 10 , wherein the cell comprises the protein encoded by the nucleic acid.

Assignments (9)
PATENT SECURITY AGREEMENT Recorded Jan 12, 2026
From: MEDLINE INDUSTRIES, LP F/K/A/ MEDLINE INDUSTRIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 074331/0430 →
PATENT SECURITY AGREEMENT Recorded Jun 20, 2025
From: MEDLINE INDUSTRIES, LP
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 071672/0100 →
PARTIAL TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jun 20, 2025
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: MEDLINE INDUSTRIES, LP (F/K/A MEDLINE INDUSTRIES, INC.); NIMA PARTNERS, INC. (AS SUCCESSOR-IN-INTEREST TO NIMA ACQUISITION, LLC)
Reel/Frame 071672/0227 →
PARTIAL TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jun 20, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: MEDLINE INDUSTRIES, LP (F/K/A MEDLINE INDUSTRIES, INC.); NIMA PARTNERS, INC. (AS SUCCESSOR-IN-INTEREST TO NIMA ACQUISITION, LLC)
Reel/Frame 071675/0957 →
PARTIAL TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS (REEL/FRAME 066971/0808) Recorded Jun 20, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: MEDLINE INDUSTRIES, LP (F/K/A MEDLINE INDUSTRIES, INC.); NIMA PARTNERS, INC. (AS SUCCESSOR-IN-INTEREST TO NIMA ACQUISITION, LLC)
Reel/Frame 071676/0356 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2025
From: NIMA ACQUISITION, LLC
To: NIMA PARTNERS, INC.
Reel/Frame 070142/0009 →
SECURITY INTEREST Recorded Apr 2, 2024
From: MEDLINE INDUSTRIES, LP
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 066971/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2023
From: NIMA LABS, INC.
To: NIMA ACQUISITION, LLC
Reel/Frame 064381/0727 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2023
From: ZHANG, JINGQING; YATES, SHIREEN TALEGHANI; SUNDVOR, SCOTT ERIK; SEIT-NEBI, ALIM
To: NIMA LABS, INC.
Reel/Frame 064381/0709 →